NUWE Stock Analysis: Buy, Sell, or Hold?
NUWE - Nuwellis, Inc. Common Stock
$1.49
-0.14 (-8.59%)
▼
5d:
-14.37%
30d:
-48.26%
90d:
+35.45%
HOLD
MODERATE Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026
4d
Get Alerted When NUWE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUWE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NUWE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NUWE is currently trading at $1.49, which is considered oversold relative to its 30-day fair value range of $2.05 to $3.35.
Technical Outlook: Technically, NUWE is in a uptrend. Immediate support is located at $1.34, while resistance sits at $6.40. Short-term momentum is weak, with the stock down 8.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+638.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUWE is in a uptrend. Immediate support is located at $1.34, while resistance sits at $6.40. Short-term momentum is weak, with the stock down 8.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+638.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.05 -
$3.35
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.6%)
- BULLISH: Trading 638.3% below Wall St target ($11.00)
- NEUTRAL: Bottoming setup forming (40/100) — watch for confirmation
- CAUTION: 5-day price weakness (-14.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.05 -
$3.35
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.34
Resistance Level
$6.40
Current Trend
Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.37
Wall Street Target
$11.00
(+638.3%)
Revenue Growth (YoY)
26.2%
Earnings Growth (YoY)
-99.2%
Profit Margin
-217.2%
Share & Embed Analysis
Last updated: August 08, 2026 5:27 AM ET
Data refreshes hourly during market hours. Next update: 6:27 AM
Data refreshes hourly during market hours. Next update: 6:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUWE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 62 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 51 HOLD |
